Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3609471 Title: FORMULATION DE (E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4- METHOXYBENZYLSULPHONE AVEC UNE STABILITÉ ET BIODISPONIBILITÉ ACCRUE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
187185723
WO application number:
US2018027514
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3609471
WO publication number:
WO2018191634
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
13/04/2018
Grant date:
04/01/2023
EP publication date:
19/02/2020
WO publication date:
18/10/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
04/01/2023
EP B1 publication date:
04/01/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/04/2023
Expiration date (if granted and all annual fees paid):
13/04/2038

Applicant

Name:
Onconova Therapeutics, Inc.
Legal Form:
From:
04/01/2023
Address:
12 Penns Trail, Newton, PA 18940, United States (US)
To:

Inventor

Name:
MANIAR, Manoj
Legal Form:
Address:
Fremont, CA 94539, United States (US)

Priority

1

Priority patent number:
201715688320
Priority date:
28/08/2017
Priority country:
United States (US)

2

Priority patent number:
201762485355 P
Priority date:
13/04/2017
Priority country:
United States (US)

3

Priority patent number:
PCT/US2017/048890
Priority date:
28/08/2017
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 9/00; A61K 9/48; A61K 47/10; A61K 31/198; A61P 35/00; A61P 35/02;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2023/01
Publication date:
24/01/2023
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2023/23
Publication date:
10/01/2024
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

1

Issue number:
202301
Publication date:
04/01/2023
Description:
Grant (B1)

2

Issue number:
202306
Publication date:
08/02/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type